Regulatory B cells in skin and connective tissue diseases

Journal of Dermatological Science

Volumn 60, Issue 1, 2010, Pages 1-7

  Fujimoto, Manabu ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

B10 cell; Contact hypersensitivity; IL 10; Regulatory B cell; Systemic lupus erythematosus

Indexed keywords

B7 ANTIGEN; CD19 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CD86 ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 10; MYELIN BASIC PROTEIN; NEUTRALIZING ANTIBODY; RITUXIMAB;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; COLITIS; CONNECTIVE TISSUE DISEASE; CONTACT ALLERGY; CYTOKINE PRODUCTION; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION; MOLECULAR MECHANICS; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PSORIASIS; REGULATORY B LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SKIN ALLERGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMOCYTE;

ANIMALS; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CONNECTIVE TISSUE DISEASES; CYTOKINES; DERMATITIS, CONTACT; ENCEPHALOMYELITIS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; MICE; SKIN DISEASES;

EID: 77957021636     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.08.010     Document Type: Review

References (50)

1. Katz S.I., Parker D., Turk J.L. B-cell suppression of delayed hypersensitivity reactions. Nature 1974, 251:550-551.
2. Mizoguchi A., Bhan A.K. A case for regulatory B cells. J Immunol 2006, 176:705-710.
3. Fillatreau S., Gray D., Anderton S.M. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol 2008, 8:391-397.
4. Mauri C., Ehrenstein M.R. The 'short' history of regulatory B cells. Trends Immunol 2008, 29:34-40.
5. DiLillo D.J., Matsushita T., Tedder T.F. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 2010, 1183:38-57.
6. Martin F., Chan A.C. B cell immunobiology in disease: evolving concepts from the clinic. Annu Rev Immunol 2006, 24:467-496.
7. Browning J.L. B cells move to centre stage: novel opportunities for autoimmune disease treatment. Nat Rev Drug Discov 2006, 5:564-576.
8. Fujimoto M., Sato S. B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity. J Dermatol Sci 2007, 46:1-9.
9. Yanaba K., Bouaziz J.D., Matsushita T., Magro C.M., St Clair E.W., Tedder T.F. B-lymphocyte contributions to human autoimmune disease. Immunol Rev 2008, 223:284-299.
10. Lund F.E., Garvy B.A., Randall T.D., Harris D.P. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr Dir Autoimmun 2005, 8:25-54.
11. Harris D.P., Haynes L., Sayles P.C., Duso D.K., Eaton S.M., Lepak N.M., et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000, 1:475-482.
12. Shlomchik M.J., Craft J.E., Mamula M.J., From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 2001, 1:147-153.
13. L'Age-Stehr J., Teichmann H., Gershon R.K., Cantor H. Stimulation of regulatory T cell circuits by immunoglobulin-dependent structures on activated B cells. Eur J Immunol 1980, 10:21-26.
14. Shimamura T., Hashimoto K., Sasaki S. Feedback suppression of the immune response in vivo. I. Immune B cells induce antigen-specific suppressor T cells. Cell Immunol 1982, 68:104-113.
15. Shimamura T., Habu S., Hashimoto K., Sasaki S. Feedback suppression of the immune response in vivo. III. Lyt-1+ B cells are suppressor-inducer cells. Cell Immunol 1984, 83:221-224.
16. Kennedy M.W., Thomas D.B. A regulatory role for the memory B cell as suppressor-inducer of feedback control. J Exp Med 1983, 157:547-558.
17. Wolf S.D., Dittel B.N., Hardardottir F., Janeway C.A. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996, 184:2271-2278.
18. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002, 3:944-950.
19. Mizoguchi A., Mizoguchi E., Takedatsu H., Blumberg R.S., Bhan A.K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002, 16:219-230.
20. Mauri C., Gray D., Mushtaq N., Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003, 197:489-501.
21. O'Garra A., Chang R., Go N., Hastings R., Haughton G., Howard M. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 1992, 22:711-717.
22. O'Garra A., Stapleton G., Dhar V., Pearce M., Schumacher J., Rugo H., et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 1990, 2:821-832.
23. Dalwadi H., Wei B., Schrage M., Spicher K., Su T.T., Birnbaumer L., et al. B cell developmental requirement for the G alpha i2 gene. J Immunol 2003, 170:1707-1715.
24. Brummel R., Lenert P. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides. J Immunol 2005, 174:2429-2434.
25. Colgan S.P., Hershberg R.M., Furuta G.T., Blumberg R.S. Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling. Proc Natl Acad Sci USA 1999, 96:13938-13943.
26. Watanabe R., Fujimoto M., Ishiura N., Kuwano Y., Nakashima H., Yazawa N., et al. CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol 2007, 171:560-570.
27. Tedder T.F., Poe J.C., Fujimoto M., Haas K.M., Sato S. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system. Curr Dir Autoimmun 2005, 8:55-90.
28. Ishiura N., Nakashima H., Watanabe R., Kuwano Y., Adachi T., Takahashi Y., et al. Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation. Eur J Immunol 2010, 40:1192-1204.
29. + phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.
30. Burke F., Stagg A.J., Bedford P.A., English N., Knight S.C. IL-10-producing B220+CD11c-APC in mouse spleen. J Immunol 2004, 173:2362-2372.
31. Evans J.G., Chavez-Rueda K.A., Eddaoudi A., Meyer-Bahlburg A., Rawlings D.J., Ehrenstein M.R., et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007, 178:7868-7878.
32. Matsushita T., Yanaba K., Bouaziz J.D., Fujimoto M., Tedder T.F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008, 118:3420-3430.
33. Lampropoulou V., Hoehlig K., Roch T., Neves P., Calderon Gomez E., Sweenie C.H., et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 2008, 180:4763-4773.
34. Shimomura Y., Mizoguchi E., Sugimoto K., Kibe R., Benno Y., Mizoguchi A., et al. Regulatory role of B-1 B cells in chronic colitis. Int Immunol 2008, 20:729-737.
35. Nakashima H., Hamaguchi Y., Watanabe R., Ishiura N., Kuwano Y., Okochi H., et al. CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions. J Immunol 2010, 184:4637-4645.
36. Tsuji R.F., Szczepanik M., Kawikova I., Paliwal V., Campos R.A., Itakura A., et al. B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J Exp Med 2002, 196:1277-1290.
37. Matsumura Y., Byrne S.N., Nghiem D.X., Miyahara Y., Ullrich S.E. A role for inflammatory mediators in the induction of immunoregulatory B cells. J Immunol 2006, 177:4810-4817.
38. Byrne S.N., Halliday G.M. B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity. J Invest Dermatol 2005, 124:570-578.
39. Korganow A.S., Ji H., Mangialaio S., Duchatelle V., Pelanda R., Martin T., et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999, 10:451-461.
40. Gray M., Miles K., Salter D., Gray D., Savill J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA 2007, 104:14080-14085.
41. Watanabe R., Ishiura N., Nakashima H., Kuwano Y., Okochi H., Tamaki K., et al. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 2010, 184:4801-4809.
42. Haas K.M., Watanabe R., Matsushita T., Nakashima H., Ishiura N., Okochi H., et al. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J Immunol 2010, 184:4789-4800.
43. Blair P.A., Chavez-Rueda K.A., Evans J.G., Shlomchik M.J., Eddaoudi A., Isenberg D.A., et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 2009, 182:3492-3502.
44. Jamin C., Morva A., Lemoine S., Daridon C., de Mendoza A.R., Youinou P. Regulatory B lymphocytes in humans: a potential role in autoimmunity. Arthritis Rheum 2008, 58:1900-1906.
45. Gantner F., Hermann P., Nakashima K., Matsukawa S., Sakai K., Bacon K.B. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides. Eur J Immunol 2003, 33:1576-1585.
46. Llorente L., Richaud-Patin Y., Fior R., Alcocer-Varela J., Wijdenes J., Fourrier B.M., et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 1994, 37:1647-1655.
47. Diaz-Alderete A., Crispin J.C., Vargas-Rojas M.I., Alcocer-Varela J. IL-10 production in B cells is confined to CD154+ cells in patients with systemic lupus erythematosus. J Autoimmun 2004, 23:379-383.
48. Amel Kashipaz M.R., Huggins M.L., Lanyon P., Robins A., Powell R.J., Todd I. Assessment of Be1 and Be2 cells in systemic lupus erythematosus indicates elevated interleukin-10 producing CD5+ B cells. Lupus 2003, 12:356-363.
49. Blair P.A., Norena L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010, 32:129-140.
50. Dass S., Vital E.M., Emery P. Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum 2007, 56:2715-2718.